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Background-—A prolonged PR interval is known to be a poor prognostic factor in cardiovascular disease. The aim of this study was
to investigate the association between PR interval and clinical outcome in patients undergoing radiofrequency catheter ablation
(RFCA) of atrial ﬁbrillation (AF).
Methods and Results-—Weprospectively included 576 patients with AF (75.5%male, 57.811.6 years old, 68.8% paroxysmal AF) who
underwent RFCA.We analyzed preprocedural sinus rhythmECGs obtained in the absence of antiarrhythmic drug, and all enrolled patients
were categorized into 4 groups based on the quartile values of the PR interval (166, 182, and 202 ms), and were analyzed according
to the left atrium (LA) volume (CT; Computed tomography), LA voltage (NavX), and clinical outcome of AF ablation. Based on quartile
value of PR interval, the highest quartile of PR interval (Q4; PR ≥202 ms) was oldest (P<0.001), and most likely to have persistent AF
(P<0.001) and hypertension (P=0.013) compared with the other groups. However, there was no signiﬁcant difference in LA conduction
velocity and atrial effective refractory period. Q4 had the greatest LA dimension (P<0.001) and volume index (P<0.001), and lowest LA
appendage-emptying velocity (P<0.032) and LA voltage (P<0.001) compared with the others. For 13.17.5 months, the classiﬁcation
based on the PR interval was a signiﬁcant predictor of AF recurrence after RFCA of AF (HR=1.969, 95% CI 1.343 to 2.886, P=0.001).
Conclusions-—The PR interval was closely associated with advanced LA remodeling due to AF, and had a noninvasive signiﬁcant
predictive value of clinical recurrence of AF after RFCA. ( J Am Heart Assoc. 2014;3:e001277 doi: 10.1161/JAHA.114.001277)
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A ttention to the P wave indices, such as the maximumduration or dispersion, and PR intervals has been increas-
ing forvariouscardiovasculardiseases includingatrialﬁbrillation
(AF). The P wave indices are signiﬁcantly prolonged in hyperten-
sion,1 diabetes,2 and cardiovascular disease.3 A prolonged PR
interval has been reported to be associated with an increased
risk of coronary artery disease, heart failure, and pacemaker
implantations.4 A large community-based cohort study revealed
a higher incidence of AF among patients with a prolonged PR
interval.5 The maintenance mechanism of AF represents a
heterogeneous focal scarring of atrial tissue and atrial structural
remodeling, which results in an inhomogeneous recovery and
slow conduction.6 Atrial substrate remodeling is initiated by
hemodynamic, oxidative, or ischemic stress and induces atrial
inﬂammation,matrix remodeling, andatrialﬁbrosis. Remodeling
associated with abnormal propagation of atrial impulses might
be reﬂected in the electrocardiography ﬁndings, such as the PR
interval or abnormal Pwave indices. A previous study has shown
ahigher recurrence rateofAFaftercardioversion inpatientswho
hadlongerPwaveindices.7However,mostAFstudiesonPwaves
were cross-sectional designed and had a short follow-up
duration or small sample size without any invasive mapping
validation.8 Therefore, we analyzed and compared the P wave
indices and PR intervals with clinical or prognostic factors and
detailed intracardiac electrophysiologic parameters in patients
who underwent radiofrequency catheter ablation (RFCA) of AF.
Our hypothesis was that the PR interval or P wave indices are
associated with the electroanatomical remodeling of the left
atrium (LA) and predict the clinical outcome of the RFCA of AF
during the long-term follow-up.
Methods
Study Population
The study protocol adhered to the Declaration of Helsinki and
was approved by the Institutional Review Board of Yonsei
University Health System. All patients provided written
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informed consent. Among 1253 consecutive patients in the
Yonsei AF Ablation Cohort (June 2009 to September 2013),
576 patients were included who had a pre-procedural ECG
with sinus rhythm without any anti-arrhythmic drug effect. The
majority of the patient population (68.8%) had paroxysmal AF
(PAF) and 31.2% had persistent AF. The study’s exclusion
criteria were as follows: (1) permanent AF refractory to
electrical cardioversion; (2) AF with moderate to severe mitral
stenosis or regurgitation, any mechanical or bioprosthetic
heart valve, or mitral valve repair; (3) associated structural
heart disease other than left ventricular hypertrophy; (4)
clinically signiﬁcant atrioventricular (AV) block ≥2nd degree,
and (5) prior AF ablation. We also excluded (6) patients who
had taken amiodarone due to its long half-life, and (7) those
did not have sinus rhythm ECG taken within a day before the
procedure. Three-dimensional (3D) spiral computed tomogra-
phy (CT) scans (64 Channel, Light Speed Volume CT; Philips,
Brilliance 63, Netherlands) were performed to visually deﬁne
the pulmonary vein (PV) anatomy. All antiarrhythmic drugs
were discontinued for a period corresponding to at least 5
half-lives. Anticoagulation therapy was maintained before the
catheter ablation.
Measurement of the Electrocardiographic
Parameters
We analyzed the standard 12-lead ECG in all patients (GE
Healthcare, Marquette, MAC5500, Waukesha, WI). The paper
speed was 25 mm/s with a calibration of 10 mm/mV. The
heart rate, PR interval, QRS, QTc, and P-axis were automatically
measured by the ECG system. The P wave analyses were
conducted in leads I, II, III, aVR, aVL, aVF, and V1 by a technician
who was blinded to the clinical characteristics. The duration
and amplitude of the P waves were manually measured using a
customized software (Cardio Calipers, version 3.3). In lead V1,
both the positive and negative P-terminal forces were mea-
sured. The technician was asked to repeat the measurement of
same ECG parameters, and the correlation coefﬁcient for the
intraclass correlation was 0.96 (P<0.001).
Echocardiographic and CT Evaluation of the Heart
All patients underwent trans-thoracic echocardiography (So-
nos 5500, Philips Medical System, Andover, MA or Vivid 7; GE
Vingmed Ultrasound, Horten, Norway) prior to the RFCA. The
chamber size, transmitral Doppler ﬂow velocity, and ratio of
the early diastolic mitral peak mitral inﬂow velocity and early
diastolic mitral annular velocity (E/Em) were acquired follow-
ing the American Society of Echocardiography guidelines.9,10
Transesophageal echocardiography was performed to exclude
any intracardiac thrombi. The emptying velocity of the LA
appendage was measured in all patients.
Electroanatomical Mapping and LA CT
Measurements
A 3D electroanatomical map (NavX; St. Jude Medical Inc,
Minnetonka, MN) was generated using a circular PV mapping
catheter (Lasso; Biosense-Webster Inc, Diamond Bar, CA). The
NavX system-generated 3D geometry of the LA and PVs was
merged with the corresponding 3D spiral CT images. LA
voltage maps were generated after circumferential PV isolation
by obtaining contact bipolar electrograms from 350 to 500
points on the LA endocardium during atrial pacing at 500 ms,
and the mean LA voltage was calculated as previously
described.11,12 A blinded technician analyzed the color-coded
CT-merged NavX voltage maps with customized software
(Image Pro) as previously described.12–14 To calculate the LA
conduction velocity, the conduction distance from the earliest
activation site at the septum to the latest activation point at
the LA appendage was measured on the anterior–posterior
view of the isochronal map and was divided by the time
difference as previously described (Figure 1).12,14 The refer-
ence distance was measured by the interelectrode distances of
the coronary sinus catheter (duodecapolar catheter; St. Jude
Medical Inc, Minnetonka, MN). The 3D spiral CT images of the
LA were analyzed on an imaging processing workstation
(Aquarius, Terarecon Inc, USA). Each LA image was divided into
portions according to the embryological origin: the venous LA,
anterior LA, and LA appendage.14 The effective refractory
periods were measured at 4 regions in both atria (high right
atrium, low right atrium, proximal and distal coronary sinus).
Radiofrequency Catheter Ablation
An open-irrigation 3.5-mm-tip deﬂectable catheter (Celsius,
Johnson & Johnson Inc, Diamond Bar, CA; Coolﬂex, St. Jude
Medical Inc, Minnetonka, MN; 30 to 35 W; 47°C) was used for
the RFCA (Stockert generator; Biosense Webster Inc, Diamond
Bar, CA). All patients initially underwent circumferential PV
isolation and the creation of cavo-tricuspid isthmus block. For
the patients with persistent AF, we added a roof line, posterior
inferior line, and anterior line15 as a standard lesion set.
Depending on the operator’s decision, additional ablation of
the superior vena cava, non-PV foci, or complex fractionated
electrograms was conducted. The procedure ended when there
was no immediate recurrence of AF after cardioversion with an
isoproterenol infusion (5 to 10 lg/min). If there were non-PV
foci under the isoproterenol infusion, we ablated them all.
Postablation Management and Follow-Up
All patients were followed with all anti-arrhythmic drugs
discontinued after the RFCA. The patients visited the outpatient
clinic regularly at 1, 3, 6, and 12 months and then every
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Table 1. Baseline Characteristics Depending on the PR Interval
Q1 (<166 ms)
(n=139)
Q2 (166 to 182 ms)
(n=128)
Q3 (182 to 202 ms)
(n=161)
Q4 (≥202 ms)
(n=148) P Value
Male, n (%) 104 (74.8) 102 (79.7) 118 (73.3) 111 (75.0) 0.640
Age, years 55.112.4 56.911.0 58.512.0 60.510.3 0.001*
Paroxysmal AF, n (%) 107 (77.0) 104 (81.3) 106 (65.8) 79 (53.4) <0.001*
BMI, kg/m2 24.62.7 24.62.9 25.02.7 24.93.1 0.593
CHADS2 score 0.91.1 0.91.0 1.21.2 1.01.0 0.098
Heart failure, n (%) 15 (10.8) 4 (3.1) 18 (11.2) 6 (4.1) 0.048*
Hypertension, n (%) 51 (36.7) 63 (49.2) 88 (54.7) 74 (50.0) 0.013*
Age >75 years, n (%) 5 (3.6) 6 (4.7) 10 (6.2) 7 (4.7) 0.766
Diabetes, n (%) 15 (10.8) 16 (12.5) 28 (17.4) 27 (18.2) 0.204
Stroke/TIA, n (%) 22 (15.8) 13 (10.2) 24 (14.9) 15 (10.1) 0.330
b-blocker, n (%) 48 (34.5) 46 (35.9) 50 (31.1) 41 (27.7) 0.458
Procedure & follow-up
Ablation time, s 4657.01596.0 4730.91473.1 4993.21477.1 5186.61766.6 0.019*
Procedure time, min 182.953.9 181.444.7 186.539.9 196.251.3 0.042*
Early recurrence, n (%) 33 (23.7) 40 (31.2) 37 (23.0) 50 (33.8) 0.107
Clinical recurrence,
n (%)
20 (14.4) 6 (4.7) 21 (13.0) 33 (22.3) 0.003*
Follow-up duration,
month
13.67.6 13.47.4 13.27.6 12.47.6 0.574
AF indicates atrial ﬁbrillation; BMI, body mass index; TIA, transient ischemic attack.
*P < 0.05.
Figure 1. The association between a prolonged PR interval and left atrial remodeling. CT indicates
computed tomography; LAA, left atrium appendage.
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6 months thereafter or whenever symptoms occurred after the
RFCA. All patients underwent electrocardiography during every
visit and24- or 48-hourHolter recording and/or event recording
at 3, 6, and every 6 months, according to the 2012HRS/EHRA/
ECAS Expert Consensus Statement guidelines.16 However,
whenever patients reported symptoms of palpitations, Holter
monitor or event monitor recordings were obtained and
evaluated for possible arrhythmia recurrences. We deﬁned a
recurrence of AF as any episode of AF or atrial tachycardia
lasting for at least 30 s in duration.17 AnyECGdocumentationof
an AF recurrence within a 3-month blanking period was
diagnosed as an early recurrence, and 3 months after a
procedure as a clinical recurrence.17
Data Analysis
Normally distributed continuous variables were expressed as the
mean SD. We compared the PR interval during sinus rhythm
prior to the ablation to the degree of electroanatomical
remodeling of the LA, echocardiographic parameters, and clinical
outcome. The cutoff values of the parametric variables were
determinedbymedianandquartile values. Statistical signiﬁcance
Table 2. The Electrophysiologic Characteristics Depending on the PR Interval
Q1 (<166 ms)
(n=139)
Q2 (166 to 182 ms)
(n=128)
Q3 (182 to 202 ms)
(n=161)
Q4 (≥202 ms)
(n=148) P Value
Electrocardiogram
Heart rate/min 63.815.3 61.010.0 60.78.3 59.510.2 0.010*
P wave duration in lead II, ms 116.015.5 122.714.3 124.016.4 131.218.9 <0.001*
P wave amplitude in lead II, mV 15.15.1 15.54.9 15.15.1 14.64.6 0.512
Negative P duration in lead V1, ms 50.825.0 52.622.9 59.625.8 62.625.2 <0.001*
Negative P amplitude in lead V1, mV 6.13.4 5.93.7 6.63.7 6.63.0 0.221
QRS duration, ms 101.032.9 99.812.7 99.614.9 105.216.3 0.077
QTc, ms 429.246.0 431.924.8 439.331.6 445.330.0 <0.001*
Echocardiogram
LA dimension, mm 40.55.9 40.35.5 42.66.4 42.76.1 <0.001*
LA volume index, mL/m2 33.912.4 31.511.1 36.813.2 38.211.4 <0.001*
LV ejection fraction, % 62.67.7 64.06.7 60.99.9 63.88.3 0.004*
E/Em 10.05.3 9.54.1 10.55.1 11.24.4 0.031*
LV mass index, g/m2 94.122.7 92.321.1 95.521.7 94.722.7 0.786
LVEDD, mm 50.14.1 49.74.2 50.14.3 49.55.0 0.624
LVESD, mm 33.93.9 32.84.4 34.44.9 33.24.7 0.025
LAA velocity (n=342), cm/s 55.123.3 53.122.3 49.822.8 45.621.2 0.032*
3D-CT
LA volume/BSA, mL/m2 76.423.4 75.926.2 84.325.7 90.923.1 <0.001*
Anterior LA/BSA, mL/m2 42.414.6 43.915.1 48.417.4 52.916.9 <0.001*
LAA/BSA, mL/m2 7.58.7 6.53.2 7.44.8 8.15.2 0.288
NavX electroanatomical map
LA voltage (n=425), mV 1.50.7 1.20.6 1.20.7 1.00.6 <0.001*
LA conduction velocity (n=345), m/s 0.40.3 0.50.3 0.40.3 0.40.3 0.404
Effective refractory period (n=443)
High right atrium, ms 227.926.9 233.227.3 229.827.8 230.724.2 0.549
Low right atrium, ms 232.033.2 232.528.5 226.835.3 228.634.0 0.551
Proximal coronary sinus, ms 241.532.9 244.940.0 256.4218.0 250.0154.3 0.833
Distal coronary sinus, ms 254.341.6 255.741.2 249.740.9 245.544.3 0.516
3D-CT indicates 3-dimensional computed tomography; E/Em, the ratio of the transmitral and myocardial early diastolic velocity; LA, left atrium; LAA, LA appendage; LVEDD, left ventricular
end-diastolic diameter; LVESD, left ventricular end-systolic diameter.
*P < 0.05.
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of the comparisons depending on the quartile of PR interval was
assessed using the ANOVA test. We also used ANOVA and
correlation analysis to assess the association between LA
conduction velocity or effective refractory periods and PR
interval. A Kaplan–Meier and Cox regression analysis was used
to analyze the recurrent AF-free survival after the catheter
ablation, and log rank test P<0.05 was considered statically
signiﬁcant. Uni- and multivariable linear regression analyses
were used to analyze the association with the PR interval. Log
minus log graph for analyzing the proportionality assumption of
PR interval shows parallel pattern according to the quartile of PR
interval. This means that the effects of PR interval are constant
regardless of time (the proportional assumption of Cox regres-
sion analysis). Variance inﬂation factors were used to measure
the colinearity in the multivariable regression analysis. A P-value
<0.05 was considered statistically signiﬁcant.
Results
A Long PR Interval Is Related to the Clinical Risk
Factors of AF
All patients were classiﬁed into 4 groups based on the quartile
value of the PR interval as depicted in Table 1. Patients who
had a long PR interval were older (P<0.001), likely to have less
paroxysmal AF (P<0.001), and more hypertension (P=0.013)
compared to those with a short PR interval, but the CHADS2
scores did not signiﬁcantly differ between the groups
(P=0.098). The procedure time (P=0.042) and ablation time
(P=0.019) were also prolonged in the long PR interval group.
A Long PR Interval Is Associated With a Long P
Wave Duration and Advanced Electroanatomical
Remodeling of the LA
Table 2 summarizes the electrophysiological and anatomical
characteristics of AF depending on the quartile values of the
PR interval during sinus rhythm. As the PR interval prolonged,
the heart rate was lower (P=0.010) and the P wave in lead II
(P<0.001) and negative P terminal force in V1 (P<0.001)
increased in duration. Likewise, the QTc interval was noted to
increase with the PR interval (P<0.001). Figure 1 shows that
as the PR interval prolonged, the LA dimension (P<0.001) and
volume (P<0.001) increased and the LA voltage decreased
(P<0.001), and the emptying velocity of the LA appendage
decreased linearly (P=0.032). These ﬁndings suggest that the
advanced electroanatomical remodeling of the LA was
associated with the prolonged PR interval (Figure 2). The LA
A B
Figure 2. A, Patients with a prolonged PR interval had an enlarged LA size and decreased LA voltage. B,
Patients with a short PR interval had a relatively small LA size and preserved LA voltage compared to those
with a prolonged PR interval. PR interval prolongation led to the clinical recurrence of AF after the RFCA. AF
indicates atrial ﬁbrillation; BSA, body surface area; LA, left atrium; PAF, paroxysmal AF; RFCA,
radiofrequency catheter ablation.
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conduction velocity and effective refractory periods did not
show any linear relationship to the PR interval.
A Long PR Interval Is a Predictor of an AF
Recurrence After Catheter Ablation
The overall clinical recurrence rate was 13.9% during 13.17.5
(3 to 37) months of follow-up, and the recurrence rate
signiﬁcantly increased as the PR interval increased (P=0.003,
Table 1). A multivariable Cox analysis showed that a long PR
interval was a predictor of an AF recurrence after the RFCA of
AF (HR=1.969, 95% CI 1.343 to 2.886, P=0.001; Table 3). A
Kaplan–Meier curve showed a signiﬁcant difference in the
recurrent AF-free survival according to the PR interval (log rank
P<0.001; Figure 3A). The results by continuous version of PR
interval were also consistent with analysis by PR interval
quartile in multivariable analysis (HR 1.014, 95% CI 1.006 to
1.023, P<0.001). These results were also consistent with the
analysis of the 283 patients who were followed up for longer
than 1 year (19.15.9 months, log rank P=0.003; Figure 3B).
Discussion
The current study showed that a prolonged PR interval
reﬂected atrial remodeling due to AF, and was associated with
a greater LA size, reduced LA voltage, and higher prevalence
of persistent AF and hypertension compared to that for a
short PR interval. In addition, the prolonged PR interval, a
noninvasive parameter, was a signiﬁcant predictor of a clinical
recurrence of AF after the RFCA.
PR Interval as Prognostic Parameter for Cardiac
Disease and AF
The PR interval reﬂects an electrical impulse that propagates
from the peri-sinus nodal tissue to the Purkinje-ventricular
muscle junction. Hence, a prolonged PR interval is affected by
the atrial conduction properties, AV nodal conduction delays,
and infranodal conduction or myocardial disease. The major
portion of the PR interval includes the P wave duration, and
there have been many studies regarding the P wave duration
Table 3. Multivariable Analysis of the Clinical Recurrence of AF
Univariable Multivariable
HR 95% CI P Value HR 95% CI P Value
Male 1.011 0.574 to 1.780 0.970 1.033 0.458 to 2.327 0.938
Age 1.014 0.992 to 1.036 0.209 0.970 0.942 to 0.999 0.046*
Persistent AF 2.042 1.248 to 3.344 0.005 2.251 0.914 to 5.546 0.078
BMI 0.959 0.877 to 1.048 0.353
Congestive heart failure 0.241 0.033 to 1.740 0.158
Hypertension 0.880 0.538 to 1.441 0.612
Age >75 years 1.624 0.651 to 4.049 0.299
DM 1.371 0.745 to 2.522 0.310
Stroke/TIA 1.207 0.615 to 2.372 0.584
LA dimension 1.027 0.987 to 1.069 0.186 1.001 0.939 to 1.066 0.981
LA volume index (echo) 1.014 0.995 to 1.033 0.145
LV ejection fraction 1.011 0.980 to 1.043 0.489
E/Em 1.009 0.964 to 1.057 0.701
LAA emptying velocity 0.989 0.973 to 1.005 0.173
LA volume index (3D-CT) 1.010 1.000 to 1.021 0.059 0.996 0.979 to 1.013 0.613
Mean LA voltage 0.464 0.269 to 0.802 0.006 0.326 0.149 to 0.714 0.005*
Ablation time 1.000 1.000 to 1.000 0.148
Sinus node dysfunction or 1 AVB 0.735 0.495 to 1.092 0.127 0.843 0.510 to 1.396 0.507
Early recurrence 3.698 2.254 to 6.068 <0.001 5.725 2.784 to 11.771 <0.001*
PR interval (quartile) 1.429 1.129 to 1.809 0.003 1.969 1.343 to 2.886 0.001*
Sample size was 265 (all parameters of which were measured), recurrence events was 36. Reference of PR interval (quartile) is Q1. AVB, atrioventricular block; 3D-CT indicates 3-
dimensional-computed tomography; AF, atrial ﬁbrillation; BMI, body mass index; DM, diabetes mellitus; E/Em, the ratio of the transmitral and myocardial early diastolic velocity; LAA, left
atrial appendage; LV, left ventricle; TIA, transient ischemic attack.
*P < 0.05.
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or dispersion related to aging,18 uncontrolled hypertension,1
diabetes,2 or obesity.19 Furthermore, a prolonged P wave
duration and dispersion have been known to be associated
with aortic stenosis,20 mitral stenosis,21 and coronary artery
disease,3 as well as hyperthyroidism,22 obstructive sleep
apnea,23 or a higher incidence of AF.24 In the current study,
we found a close association between the PR interval and P
wave duration, and a prolonged PR interval predicted the
clinical recurrence of AF after catheter ablation. The pro-
longed PR interval was associated with an increased risk of
AF, pacemaker implantations, and all-cause mortality in the
Framingham Heart Study,5 but was not associated with
mortality or hospitalization in another population study.25
Potential Mechanisms of PR Prolongation in AF
Increased atrial pressure, ischemia, and hemodynamic
changes result in atrial remodeling including atrial ﬁbrosis
and inﬂammation.26 This remodeling leads to an inhomoge-
neous recovery and slow conduction throughout the atrium.
As AF leads to atrial remodeling and sinus node dysfunc-
tion,27,28 the PR interval becomes prolonged. In the current
study, an enlarged atrial size or decreased atrial endocardial
voltage was associated with an increased PR interval and P
wave duration. In addition, the patients with a prolonged PR
interval had a signiﬁcantly decreased heart rate compared to
those with a short PR interval in accordance with a study in
male athletes, where the predictors of AF were a prolonged
PR interval and resting bradycardia.29 Moreover, a low heart
rate with moderate exercise is known to be a long-term
predictor of incident AF30 related to an increased vagal tone
and autonomic remodeling. A recent meta-analysis on
genomewide association studies identiﬁed the genetic loci
that are associated with the PR interval, and this suggests
that genetic variations also play important roles in the atrial
and AV conduction.31,32 Ultimately, the PR interval may be a
signiﬁcant predictor of the clinical recurrence after RFCA of
AF, which would represent the remodeling of the sinus node,
atrial substrate, AV node, or cardiac autonomic nervous
system, as well as a genetic propensity. However, it is notable
that patients in Q1 (PR interval <166 ms) had a poorer
clinical outcome than those in Q2 (PR interval 166 to 182 ms)
in the current study, and for this reason further study is
warranted.
Limitations
This study was a retrospective observational study from a
Cohort registry that included a highly selective group of
patients referred for AF catheter ablation. The enrolled
A B
Figure 3. The Kaplan–Meier curve for the recurrent AF-free survival after the RFCA of AF. A, The
patients with a prolonged PR interval had a poor recurrent AF-free survival after the RFCA of AF as
compared to those with a short PR interval. B, These results were also consistent with the analysis of the
patients with a follow-up of >1 year. AF indicates atrial ﬁbrillation; RFCA, radiofrequency catheter
ablation.
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population in this study had a relatively low number of
comorbidities. Therefore, these results cannot be generalized
to a wider population of AF. Although there was no statistical
difference between the groups, 32.1% of the patients included
were on b-blockers. We did not measure the AH or HV interval
to determine conduction in the AV node; thus, we could not
explain how the conduction delay in the AV node might have
affected the PR interval prolongation. Although we tried to keep
the consistent standard ablation protocols for PAF and
persistent AF as much as we could, there were some additional
ablations depending on the operator’s decision. These individ-
ually variable ablation lesions can affect the outcome after
RFCA. The clinical recurrence rate after a single procedure was
relatively low in this study compared with the previous
reports.33 It might be due to a small-size heart and thin-walled
atria in Asian patients. Because of frequently recurring AF at
baseline, we measured conduction time after circumferential
PV isolation and cardioversion. If there was frequently recurring
AF after cardioversion, we could not measure conduction time.
This selection bias can contribute to the lack of relationship
between PR interval and conduction velocity. Rate-related
conduction slowing was reported to be predictive for the AF
mechanism,34 so that measuring PR interval with different
pacing cycle length might be valuable for further study.
Conclusions
A prolonged PR interval reﬂects atrial remodeling in patients
with AF, and is a signiﬁcant predictor of the clinical recurrence
of AF after RFCA.
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